Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_assertion type Assertion NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_head.
- NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_assertion description "[Therefore, orexin receptor controlling hypothalamic insulin/leptin actions may be a new target for possible future treatment of hyperglycaemia in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_provenance.
- NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_assertion evidence source_evidence_literature NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_provenance.
- NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_assertion SIO_000772 19489767 NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_provenance.
- NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_assertion wasDerivedFrom befree-20150227 NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_provenance.
- NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_assertion wasGeneratedBy ECO_0000203 NP533991.RA4JxvpokDTCEIzG6o5DRQTzUkWUcfEi0JOgt9YMhv8yY130_provenance.